Acellular Dermal Matrix Market Size, Share, Growth, Trends, and Global Industry Analysis: By Origin (Animal Dermis, Human Dermis), By Application (Reconstructive Surgery, Dental, Wound Care, Others), By Technology (Cross-linked ADMs, Dehydrated ADMs, Freeze-dried ADMs, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others) and Region Forecast 2020-2031

Acellular Dermal Matrix Market size was valued at US$ 9.9 billion in 2024 and is expected to reach US$ 21.9 billion by 2031, growing at a significant CAGR of 12.1% from 2025-2031. The market refers to the biotechnology industry focusing on biologically derived products lacking cells. These matrices are typically sourced from various origins, including human dermis, animal dermis, porcine dermis, and bovine dermis. Key components of acellular dermal matrices include elastic fibres and collagen. They are a bioactive matrix, cell repopulation, supporting revascularization, and tissue remodeling.

The use of acellular dermal matrices in general surgery, plastic surgery, cosmetic surgery, breast reconstruction, and wound healing has increased significantly in the last several years. Therefore, it is anticipated that a growing number of these procedures will drive significant demand prospects in the worldwide acellular dermal matrices market. Acellular dermal matrices are also much sought after in dentistry, orthopedics, and tissue replacement and repair. This feature is probably going to help the acellular dermal matrices market growth in the future.

The companies operating in the worldwide market for acellular dermal matrices are making significant investments in R&D. Furthermore, a lot of participants are concentrated on growing their companies through merger and acquisition activity. The Zimmer Biomet acquisition of A&E Medical Corporation serves as one example.